BIM-018

BIM-018 is a synthetic cannabinoid that is the benzimidazole analog of JWH-018. It is presumed to be a potent agonist of the CB2 receptor and has been sold online as a designer drug.[1]

BIM-018
Legal status
Legal status
Identifiers
IUPAC name
  • 2-(naphthalene-1-carbonyl)-1-pentyl-1H-1,3-benzodiazole
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC23H22N2O
Molar mass342.442 g·mol−1
3D model (JSmol)
SMILES
  • CCCCCn1c2ccccc2nc1C(=O)c1cccc2c1cccc2
InChI
  • InChI=1S/C23H22N2O/c1-2-3-8-16-25-21-15-7-6-14-20(21)24-23(25)22(26)19-13-9-11-17-10-4-5-12-18(17)19/h4-7,9-15H,2-3,8,16H2,1H3
  • Key:ZJWSSWFQIOEVCU-UHFFFAOYSA-N

Related benzimidazole derivatives have been reported to be highly selective agonists for the CB2 receptor.[2]

See also

References

  1. "BIM-018". Cayman Chemical. Retrieved 24 July 2015.
  2. Pagé D, Balaux E, Boisvert L, Liu Z, Milburn C, Tremblay M, et al. (July 2008). "Novel benzimidazole derivatives as selective CB2 agonists". Bioorganic & Medicinal Chemistry Letters. 18 (13): 3695–700. doi:10.1016/j.bmcl.2008.05.073. PMID 18522867.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.